logo
Medics struggle to revive Sudan's hungry with trickle of aid supplies

Medics struggle to revive Sudan's hungry with trickle of aid supplies

Reuters19-03-2025
SHARG ELNIL, Sudan, March 19 (Reuters) - In a nutrition ward at a hospital in Sudan's war-stricken capital, gaunt mothers lie next to even thinner toddlers with wide, sunken eyes.
The patients at Alban Jadeed Hospital are in urgent need of help after nearly two years of battles that have trapped residents and cut off supplies, but doctors have to ration the therapeutic milk and other products used to treat them.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The war that erupted in April 2023 from a power struggle between Sudan's army and the paramilitary Rapid Support Forces (RSF) has created what the United Nations calls the world's largest and most devastating humanitarian crisis.
About half of Sudan's population of 50 million now suffer some degree of acute hunger, and famine has taken hold in at least five areas, including several parts of North Darfur State in western Sudan.
The real situation could be worse, since fighting has prevented proper data collection in many areas, medics and aid staff say.
In Sudan's greater capital, where the cities of Khartoum, Omdurman and Bahri are divided by the Nile, the warring factions have prevented deliveries of aid and commercial supplies, pushing the prices of goods beyond most people's reach.
Alban Jadeed Hospital, in Bahri's Sharg Elnil district, received more than 14,000 children under five years old suffering from severe acute malnutrition last year, and another 12,000 with a more mild form, said Azza Babiker, head of the therapeutic nutrition department.
Only 600 of the children tested were a normal weight, she said.
The supply of therapeutic formula milk via U.N. children's agency UNICEF and medical aid agency MSF is insufficient, Babiker said, as RSF soldiers twice stole the supplies.
Both sides deny impeding aid deliveries.
The sharp reduction of USAID funding is expected to make things worse, hitting the budgets of aid agencies that provide crucial nutritional supplies as well as community kitchens relied upon by many, aid workers say.
The army recently captured Sharg Elnil from the RSF, as part of recent gains it has made across the capital.
Fruit and vegetables have become extremely scarce. "Aside from the difficulty of getting these products in, not all families can afford to buy them," Babiker said.
Many mothers are unable to produce milk, often due to trauma resulting from RSF attacks, or their own malnutrition, said Raneen Adel, a doctor at Alban Jadeed.
"There are cases who come in dehydrated ... because for example the RSF entered the house and the mother was frightened so she stopped producing breast milk, or she was beaten," she said.
The RSF did not immediately respond to a request for comment.
A lack of nutrition and sanitation has led to cases of blood poisoning and other illnesses, but the hospital has also run out of antibiotics.
"We had to tell the patients' companions to get (the drugs) from outside, but they can't afford to buy them," Adel said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Centene posts surprise loss as medical costs surge, shares slump
Centene posts surprise loss as medical costs surge, shares slump

Reuters

time6 hours ago

  • Reuters

Centene posts surprise loss as medical costs surge, shares slump

July 25 (Reuters) - Centene (CNC.N), opens new tab on Friday posted a surprise quarterly loss, in yet another disappointment for investors in the sector that has suffered a series of setbacks due to rising costs in government-backed insurance plans. Shares of the company tumbled 14.5% in premarket trading, dragging down peers Elevance (ELV.N), opens new tab and Molina Healthcare (MOH.N), opens new tab, which have also warned of elevated costs in government-backed insurance plans. The insurance sector has been under strain for the past two years due to rising medical costs. On one hand, insurers are grappling with increased utilization of behavioral health services, home care, and high-cost drugs, while on the other, the expiration of pandemic-era subsidies and Medicaid protections has shifted enrollment toward sicker members, squeezing their margins. Centene, which largely focuses on government-sponsored plans, posted a medical cost ratio (MCR) of 93% for the quarter, well above Wall Street's expectation of 89.3% and a clear sign of pressure across all business lines. "The medical cost ratio for the quarter was surprisingly high and appeared related to all major lines of business, although its individual exchange business was likely the biggest culprit," said Morningstar analyst Julie Utterback. The quarterly loss was largely attributed to a downward revision in expected 2025 risk adjustment revenue, part of the Affordable Care Act's mechanism to balance costs across insurers. The adjustment, combined with rising Medicaid expenditure drove Centene to a second-quarter adjusted loss of $0.16 per share, versus an expected profit of $0.86, according to data compiled by LSEG. "We are disappointed by our second-quarter results, but we have a clear understanding of trends that have impacted performance, and are working with urgency and focus to restore our earnings trajectory," CEO Sarah London said. Centene said it would provide 2025 earnings expectations on the conference call. The company is in the process of requesting premium increases for Obamacare plans for 2026 to reflect a higher proportion of sicker patients who need more medical care, than it previously expected. Centene expects to be able to take corrective pricing actions for 2026 in states that represent a substantial majority of its membership in those plans.

HCA raises annual profit forecast on resilient demand for medical care
HCA raises annual profit forecast on resilient demand for medical care

Reuters

time7 hours ago

  • Reuters

HCA raises annual profit forecast on resilient demand for medical care

July 25 (Reuters) - HCA Healthcare (HCA.N), opens new tab raised its 2025 profit forecast on Friday as it expects sustained demand for medical procedures to cushion a hit from U.S. President Donald Trump's potential tariffs. Health insurers have flagged higher-than-anticipated costs in its individual plans that come under the Affordable Care Act, also known as Obamacare, and its Medicaid plans for low-income people. Analysts have said they expect this trend to benefit hospital operators, but warned that proposed federal budget cuts could hit their earnings. HCA earned second-quarter adjusted profit of $6.84 per share, beating analysts' estimates of $6.25 per share, according to data compiled by LSEG. The company expects 2025 profit to be about $25.50 to $27 per share, compared with its previous forecast of $24.05 to $25.85 per share.

EU regulator does not recommend approval of Sarepta's muscle disorder gene therapy
EU regulator does not recommend approval of Sarepta's muscle disorder gene therapy

Reuters

time7 hours ago

  • Reuters

EU regulator does not recommend approval of Sarepta's muscle disorder gene therapy

July 25 (Reuters) - Europe's medicines regulator did not recommend the approval of Sarepta Therapeutics' (SRPT.O), opens new tab gene therapy Elevidys for a type of rare muscular dystrophy, the health agency said on Friday. Shares of the company were down nearly 17% at $10.70 in premarket trading. The EU committee's negative opinion comes as yet another setback for the company that is facing increasing regulatory scrutiny after two recent deaths of patients who received Elevidys. Sarepta and its partner outside the U.S., Roche (ROG.S), opens new tab, did not immediately respond to Reuters' requests for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store